Study Goals and Research Objectives The purpose of the study is the first step in determining dosage
Patients experiencing active gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, bloating, or early satiety appear particularly susceptible to delayed gastric clearance
For those building muscle while on GLP-1 medications , the increased protein demands create another reason to prioritize hydration
Finally, the applicant stated that, under the regulation at 419.66(a), CMS makes a pass-through payment for a medical device that meets the requirements in paragraph (b) of that section and that is described by a category of devices established by CMS under the criteria in paragraph (c) of that section, and that, further, according to 419.66(g), the pass-through period begins on the first date on which pass-through payment is made